Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2Phase 3 Interventional Results available

A Study to Evaluate Albumin and Immunoglobulin in Alzheimer's Disease

ClinicalTrials.gov ID: NCT01561053

Public ClinicalTrials.gov record NCT01561053. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 22, 2026, 12:25 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Multicenter, Randomized, Controlled Study To Evaluate The Efficacy and Safety of Short-Term Plasma Exchange Followed by Long-Term Plasmapheresis With Infusion of Human Albumin Combined With Intravenous Immunoglobulin In Patients With Mild-Moderate Alzheimer's Disease

Study identification

NCT ID
NCT01561053
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2, Phase 3
Lead sponsor
Instituto Grifols, S.A.
Industry
Enrollment
347 participants

Conditions and interventions

Interventions

  • Albumin 5% Biological
  • Albumin 20% Biological
  • Immunoglobulin Biological

Biological

Eligibility (public fields only)

Age range
55 Years to 85 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Apr 18, 2012
Primary completion
Mar 5, 2018
Completion
Mar 5, 2018
Last update posted
Jul 30, 2019

2012 – 2018

United States locations

U.S. sites
22
U.S. states
11
U.S. cities
20
Facility City State ZIP Site status
Northern California Research Sacramento California 95821
Mountain View Clinical Research, Inc Denver Colorado 80209
Howard University Washington D.C. District of Columbia 20059
Bradenton Research Center, Inc. Bradenton Florida 34205
Quantum Laboratories Deerfield Beach Florida 33064
Galiz Research, LLC Hialeah Florida 33016
Largo Medical Center Largo Florida 33770
L&L Research Choices, Inc Miami Florida 33144
Allied Biomedical Research Institute Miami Florida 33155
Miami Dade Medical Research Institute, LLC Miami Florida 33176
Neurology Associates of Osmond Beach Ormond Beach Florida 32174
PharmaSeek LLC (DMI Research) Pinellas Park Florida 33782
iResearch Atlanta, LLC Decatur Georgia 30030
RTR Medical Group Savannah Georgia 31419
Dartmouth-Hitchcock Medical Center Lebanon New Hampshire 03756
The NeuroCognitive Institute Mount Arlington New Jersey 08756
Mid-Atlantic Geriatric/ARC Paterson New Jersey 08759
The Cleveland Clinic Foundation Cleveland Ohio 44195
Neurology Specialists Inc Dayton Ohio 45417
University of Pittsburgh Medical Center Pittsburgh Pennsylvania 15213
Roper St. Francis Healthcare Charleston South Carolina 29401
Wesley Neurology Clinic Cordova Tennessee 38018

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 18 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01561053, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jul 30, 2019 · Synced Jul 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT01561053 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →